Background: This study aimed to analyze the influence of the primary site of tumor location on off-pump coronary artery bypass grafting (OPCABG) surgery combined with concurrent tumor resection and to identify factors affecting long-term survival.
Methods: Fifty-seven patients with coronary artery disease (CAD) and malignancy who underwent simultaneous surgery retrospectively were enrolled. The primary site of tumor locations and cancer stage were used as a basis for grouping. The long-term survival among the subgroups was compared, and the risk factors related to survival were analyzed.
Results: The median follow-up period was 40 months. The 5-year cumulative survival rate of patients undergoing OPCABG and tumor resection was 74%. There was no significant difference in long-term survival among the four oncological location subgroups (P = 0.8), while significant difference was found among the two cancer stage subgroups (P = 0.0076). On univariable and multivariable Cox regression analysis, only cancer stage was an independent predictor of the long-term mortality rate (hazard ratio 5.42, P = 0.007).
Conclusion: For patients with potentially curable cancer and surgically correctable CAD, the safety of simultaneous surgery is confident. The primary site of tumor location does not significantly affect the long-term survival of these patients. The long-term survival rate strongly correlates with tumor stage.
Aim: The aim of this study was to analyze the influence of the
primary site of tumor location on off-pump coronary artery bypass
grafting (OPCABG) surgery combined with concurrent tumor resection, and
to identify factors affecting the long-term survival. Materials
and methods: 57 patients with coronary artery disease (CAD) and
malignancy underwent simultaneous surgery were retrospectively enrolled.
The primary site of tumor locations and cancer stage were used as a
basis for grouping. The long-term survival among the subgroups was
compared, and the risk factors related to survival was analyzed.
Results: The median follow-up period was 40 months. The 5-year
cumulative survival rate of patients undergoing OPCABG and tumor
resection was 74%. There was no significant difference in long-term
survival among the 4 oncological location subgroups (P=0.8) while
significant difference was found among the 2 cancer stage subgroups
(P=0.0076). On univariable and multivariable Cox regression analysis,
only cancer stage was an independent predictor of the long-term
mortality rate (hazard ratio 5.42, P = 0.007). Conclusion:
For patients with potentially curable cancer and surgically correctable
CAD, the safety of simultaneous surgery is confident. The primary site
of tumor location does not significantly affect the long-term survival
of these patients. The long-term survival rate strongly correlates with
tumor stage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.